(IN BRIEF) Brenntag Pharma has entered into an exclusive distribution partnership with Indovinya Belgium N.V., part of the Indorama Group, for Oxipurity® polyethylene glycols and polysorbates used in pharmaceutical and nutraceutical applications across France, Italy, Belgium, the Netherlands, Denmark, Finland, … Read the full press release →
Posted in Belgium, Business, Chemicals, Denmark, Finland, France, Italy, Netherlands, Norway, Pharma & Biotech, Sweden
Tagged ANVISA, Belgium, Brenntag, Brenntag and Indovinya Expand European Pharmaceutical Partnership With Exclusive Excipient Distribution Agreement, Brenntag Pharma, Brenntag Pharma Strengthens Formulation Offering With Indovinya Oxipurity® Polyethylene Glycols and Polysorbates, Brenntag Secures Exclusive European Distribution Rights for Indovinya Oxipurity® Excipients in Key Pharma Markets, Denmark, EP, Europe, European Pharmacopoeia, EXCiPACT, exclusive distribution agreement, Fabiana Citraro Marra, Finland, formulation development, France, GMP, Good Manufacturing Practices, hard capsules, Indorama Group, Indovinya, Indovinya Belgium N.V., ingredient distribution, IPEC-PQG, Italy, Joakim Rehné, Macrogols, Netherlands, non-ionic surfactants, Norway, nutraceutical excipients, nutraceutical formulations, oral liquids, Oxipurity, Oxipurity 4000, Oxipurity 7080, PEGs, pharmaceutical excipients, pharmaceutical formulations, pharmaceutical ingredients, Polyethylene glycols, polysorbates, regulatory compliance, soft capsules, specialty chemicals, suppositories, Sweden, tablets, topical preparations, United States Pharmacopeia, USP